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Abstract
Cyanobacterial toxins are a growing threat to human and animal welfare in many parts of the world. Microcystin-LR is 
the most widely studied of the cyanotoxins and has been implicated with hepatotoxicity, neuropathology, and genotoxicity. 
Numerous studies investigated the effect of microcystin-LR exposure on the proteome using various animal models, and 
together they form a large database of potential protein biomarkers. However, it is extremely difficult to establish which 
proteins are specifically affected by microcystin-LR, and which represent a more general toxin response. The goal of this 
review was to filter out inconsistently reported protein abundancy changes after microcystin-LR exposure. We explored 
online search engines for studies investigating the effect of microcystin-LR toxicity on the proteome. The selected studies 
were examined to find overlapping protein abundancy changes. The protein names, their synonyms, and relevant orthologues 
were used as search terms. This review has produced, for the first time, a comprehensive list of proteins whose abundancies 
changed in at least two proteomic studies investigating microcystin-LR toxicity in rodents and zebrafish. Proteins involved 
in oxidoreductase activity and cytoskeletal processes are persistently affected by microcystin-LR exposure. Several oxidative 
stress markers are consistently altered across multiple proteomic studies, which correlates with findings from epidemiological 
studies that linked chronic microcystin exposure to increased incidences of liver and colorectal cancer. This study unveils 
which proteins’ abundancies are consistently altered after microcystin-LR exposure and opens new doors to understanding 
the mechanisms behind microcystin-LR toxicity.
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Introduction
The growing worldwide presence of toxin-producing cyano-
bacteria has become an increasing concern. Also known as 
blue–green algae, these photosynthetic prokaryotes can be 
found in lakes, ponds, and rivers across the globe (van Apel-
doorn et al. 2007). They form a serious threat to the environ-
ment and human health when undergoing proliferation, a 
process called ‘blooming’. Increased eutrophication of fresh-
water bodies, often caused by industrial pollution, may lead 
to cyanobacterial blooming (Pitois et al. 2001). Fueled by an 
abundance of nutrients, cyanobacteria not only increase in 
numbers exponentially, certain species additionally produce 
an increasing amount of toxic secondary metabolites. These 
compounds are also known as cyanotoxins (van Apeldoorn 
et al. 2007).
Microcystins are among the most studied cyanotoxins. 
With a molecular mass of around 1000 Da, microcystins 
are relatively large natural products. They contain seven 
peptide-linked amino acids, of which the terminal amino 
acids are condensed, making microcystin a cyclic compound 
(Meneely and Elliott 2013).
Microcystin-LR (MC-LR) is believed to be one of the 
most toxic variants of the microcystins. It binds to the 
catalytic center of serine/threonine protein phosphatases, 
including protein phosphatases 1 and 2A (PP1 and PP2A) 
(Runnegar et al. 1995). The catalytic subunits of PP1 and 
PP2A associate to different regulatory subunits to form holo-
enzymes, allowing the regulation of DNA replication, cell 
differentiation, metabolism, apoptosis, and other key cellular 
functions (Garcia et al. 2003). Because microcystins block 
the active sites of PP1 and PP2A, protein phosphatase activ-
ity is inhibited. This leads to hyperphosphorylation of pro-
teins, which perturbs the phosphorylation/dephosphorylation 
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balance, affecting various cellular functions PP1 and PP2A 
are involved in (Gehringer 2004).
MC‑LR Toxicity in Animals
Multiple animal toxicology studies found dose-dependent 
hepatic injury and altered changes in liver enzyme levels 
after oral MC-LR exposure in mammals (Heinze 1999; 
Fawell et al. 1999; Sedan et al. 2015), though not every 
study reported an effect (Ueno et al. 1999). In a short-term 
exposure study in mice, animals were treated with MC-LR 
by oral gavage for 13 weeks daily (Fawell et al. 1999). Liver 
pathology was visible in some of the rodents (200 µg/kg 
bodyweight concentration), though at the highest concentra-
tion (1000 µg/kg bodyweight) all mice showed signs of hepa-
totoxicity. The no observed adverse effect level (NOAEL) of 
MC-LR for liver damage was 40 µg/kg bodyweight. Based 
on this NOAEL, the World Health Organization (WHO) set 
a guideline value for MC-LR. They applied an uncertainty 
factor of 1000 to the NOAEL (100 for intra- and interspe-
cies variation, 10 for limitations in the database) and set the 
tolerable daily intake (TDI) at 0.04 µg/kg bodyweight per 
day (Chorus and Bartram 1999). The guideline value for 
MC-LR is 1 µg/L (cell-bound and extracellular) in drinking 
water (Chorus and Bartram 1999).
MC‑LR Toxicity in Humans
There are various routes through which humans can be 
exposed to microcystins. The most direct route is through the 
ingestion of contaminated water, for example, by consuming 
compromised drinking water or by performing recreational 
activities in polluted waterbodies. A more indirect way of 
ingesting microcystins is through the consumption of micro-
cystin-containing foods. Indeed, microcystins bioaccumulate 
in various animals used for human consumption, including 
fish (Mohamed et al. 2003; Magalhães et al. 2003; Xie et al. 
2005), snails (Lance et al. 2010), and crustaceans (Magal-
hães et al. 2003). Microcystins also enter the human food 
chain when crops are irrigated using contaminated water. 
The toxins have been found in lettuce (Codd et al. 1999), but 
also in cabbage, radish, rocket, dill, and parsley (Mohamed 
and Al Shehri 2009).
Well-documented cases of acute microcystin toxicity in 
humans are scarce. However, one tragic incident in Brazil 
has shown the fatal effects microcystins can have on human 
health. In February 1996, hemodialysis patients received 
water that had not been properly treated (Jochimsen et al. 
1998). As a result, the dialysate contained microcystins and 
patients reported symptoms. These included muscle weak-
ness, visual disturbance, nausea, and vomiting (Jochimsen 
et al. 1998). During this outbreak, 85% of the victims expe-
rienced acute liver injury, and nearly 48% died (Pouria et al. 
1998). In the month following the outbreak, patients had a 
more than sevenfold increase in liver function enzyme serum 
aspartate aminotransferase concentrations, in addition to a 
more than fourfold increase in total and conjugated biliru-
bin (Jochimsen et al. 1998). Liver histology showed acute 
toxic hepatitis, similar to that seen in animals exposed to 
microcystins (Pouria et al. 1998). Using immunoassays, it 
was found that microcystins were present in serum samples 
at concentrations ranging from below 1 ng/mL to 10 ng/
mL, whereas in liver this was below 0.1 ng/mg to 0.4 ng/
mg liver tissue (Carmichael et al. 1996; Pouria et al. 1998). 
Mass spectrometry analyses confirmed the presence of 
microcystin-AR, MC-LR and microcystin-YR (Carmichael 
et al. 1996; Pouria et al. 1998).
While the fatal incident in Brazil exposed the dangers of 
microcystins to humans, chronic exposure to low microcys-
tin concentrations is much more common. Several epidemio-
logical studies have looked at the effect of oral microcystin 
exposure in humans. In 1983, it was reported that a drinking 
water supply was contaminated with water from a reservoir 
containing a toxic Microcystis bloom in Armidale, Australia. 
A retrospective study statistically analyzed the activity of 
liver function enzymes in exposed and non-exposed resi-
dents (Falconer et al. 1983; Falconer 2005). The authors dis-
covered a significant increase in gamma glutamyl transferase 
activity in plasma samples from the exposed group during 
the bloom, whereas no significant alterations in activity were 
found 6 weeks before and six weeks after the bloom (Fal-
coner et al. 1983). In addition, Chen and colleagues discov-
ered irregular liver function enzyme levels in serum samples 
from local fishermen at Lake Chaohu, a waterbody regularly 
plagued by dense cyanobacterial blooms (Chen et al. 2009). 
The results showed a positive correlation between microcys-
tin serum concentrations and liver function enzymes alanine 
aminotransferase (ALT), aspartate aminotransferase, lactate 
dehydrogenase, and alkaline phosphatase. In addition, Li 
et al. detected that children who consumed drinking water 
sourced from microcystin-contaminated lakes had signifi-
cantly higher levels of liver function enzymes than the con-
trol population (Li et al. 2011b).
These epidemiological studies revealed a correlation 
between microcystin exposure in humans and hepatotoxicity, 
further suggesting that microcystins may form a health haz-
ard. This makes it crucial to get a better understanding of the 
mechanisms behind MC-LR toxicity, as well as to identify 
which components of the cellular machinery are affected.
MC‑LR and the Proteome
There are various tools in place to study components of 
whole biological systems. Indeed, advancements in ‘omics’ 
technologies have enabled the analysis of a large number of 
molecules across different levels of biological organization. 
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In toxicology, such studies have allowed the identification 
and quantification of biomarkers in response to xenobiotics.
A proteome study is intended to interrogate the entire 
set of proteins present in the model of interest (e.g., a cell, 
tissue or organism). In the case of toxicology studies in 
animals, the proteomes of a treatment group are usually 
compared with that of a control (untreated) group. Differ-
ences in protein levels between the treatment and control 
group, in theory, are caused by the administered xenobiotic. 
Further downstream applications are performed for protein 
identification and validation. Once a list of affected proteins 
has been made, functional analysis may reveal interactions 
and pathways relevant to understanding the toxin’s mode of 
action. Thus, proteomic studies allow the investigation of a 
large set of proteins in response to a xenobiotic compound, 
making it a very useful tool for biomarker discovery.
The effect of MC-LR exposure on the proteome has been 
investigated in rodents and zebrafish (Table 1). While these 
studies give valuable insights, it is difficult to translate the 
results into a human scenario because of the experimental 
designs applied. Indeed, most studies administered MC-LR 
via intraperitoneal injection (IP) and used high toxin con-
centrations. This despite the fact that the most common route 
of MC-LR uptake for humans is through chronic low-dose 
oral exposure, e.g., by drinking from a contaminated water 
source. This makes it challenging to assess whether the 
observed effects in these studies are (1) truly representa-
tive for MC-LR, or rather caused by a non-specific toxin 
response due to the intense dosing nature, and (2) whether 
chronic low-dose oral exposure would generate similar 
results. Only one published proteomic study has looked at 
the effect of chronic oral MC-LR exposure in mammals (He 
et al. 2017), and the lowest concentration used was 40 µg/
kg bodyweight per day. This equates to a thousand times 
higher dose than the TDI of 0.04 µg/kg bodyweight set by 
the WHO, and it is questionable whether any humans or 
indeed animals are exposed to such high MC-LR concentra-
tions on a frequent basis.
Therefore, the goal of this review is to provide a clearer 
picture of MC-LR toxicity by identifying re-occurring 
changes in protein abundancies reported in proteomic stud-
ies that investigated the effect of MC-LR toxicity in rodents 
and zebrafish, as well as to discuss how these results may 
relate to human exposure conditions.
Methods
Due to the high number of reported MC-LR biomarkers 
in the proteome, and the often extreme parameters used in 
the experimental designs, it is difficult to determine which 
effects are specific to MC-LR toxicity. We reasoned that if 
changes in a certain protein’s abundancy were to be specific 
to MC-LR exposure, this trend would repeat itself over mul-
tiple studies. To this end, a table was constructed that lists 
proteins whose abundancies were altered in at least two pro-
teomic studies investigating MC-LR exposure in rodents and 
zebrafish (Table 1). While this method does not guarantee 
that the proteins listed in Table 1 are specific to MC-LR 
toxicity, the fact that their levels were altered across multiple 
studies increases the likelihood. Importantly, it should be 
kept in mind that some of these proteins may simply rep-
resent a general toxin response, as it is hard to distinguish 
unique MC-LR biomarkers from proteins involved in uni-
versal toxin responses.
Database Searches
To identify relevant studies that investigated the effect of 
MC-LR on the proteome, search engines PubMed (https ://
www.ncbi.nlm.nih.gov/pubme d/), Google Scholar (https ://
schol ar.googl e.com/), and Web of Science (https ://webof 
knowl edge.com/) were used. The latest search performed 
was in June 2018. The following keywords served as search 
terms: microcystin-LR, MC-LR, microcystin, microcystins, 
proteome, proteomics, systems biology, systems toxicology. 
Studies were considered relevant if the authors investigated 
the effect of MC-LR on the proteome using untargeted pro-
teomic methods, such as 2-dimensional electrophoresis 
(2DE) and isobaric tags for relative and absolute quantifi-
cation (iTRAQ). Only investigations that had rodents and 
zebrafish as the experimental model were included. Where 
applicable, reported accession numbers were validated on 
the National Center for Biotechnology Information Pro-
tein database (https ://www.ncbi.nlm.nih.gov/prote in/) and 
UniProt (https ://www.unipr ot.org/). Searches for individual 
accession numbers and protein names were performed on 
UniProt and Ensembl (https ://www.ensem bl.org/index .html, 
release 89) databases to find potential synonyms and ortho-
logues. The protein names, accession numbers, synonyms, 
and orthologues (including their potential synonyms) were 
subsequently used as search terms in Acrobat Reader DC 
software (Adobe, version 2017.009.20044) in order to find 
overlapping reports of individual biomarkers among the 
proteomic studies. In cases where the original file was not 
accessible by Acrobat Reader DC software, for example, 
when the list of biomarkers was published in a supplemen-
tary Microsoft Word document, the file was converted to the.
pdf file format that could be included to the simultaneous 
search. This resulted in a list of proteins whose abundan-
cies were altered in at least two proteomic investigations 
studying MC-LR toxicity (Table 1). The protein names 
listed in Table 1 are those recommended by UniProt (release 
2018_01) and may be different from the synonyms reported 
by the investigated proteomic studies.
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Protein Classification
In order to get a broader overview of the molecular functions 
influenced by MC-LR, classification system PANTHER 
(https ://panth erdb.org) was used for functional classifica-
tion. To this end, human orthologues of the proteins listed in 
Table 1 were compared to the Homo sapiens reference data-
base (PANTHER 13.1 release). This was done separately 
for proteins found in the liver and brain. The resulting data 
were visualized (Fig. 1) using the ggplot2 package (https ://
ggplo t2.org) in R (https ://www.r-proje ct.org/). PANTHER’s 
statistical overrepresentation test utility determined which 
molecular functions were overrepresented in the liver and 
brain compared to the Homo sapiens reference database 
(PANTHER 13.1 release). The statistical method applied 
by the PANTHER algorithm was the Fisher’s exact test with 
false discovery rate (FDR) multiple test correction.
Commonly Reported Protein Changes in 2DE 
Analyses
In order to make a better distinction between potential 
MC-LR biomarkers and proteins whose abundancies change 
frequently across 2DE studies, the results from two stud-
ies were used (Petrak et al. 2008; Wang et al. 2009). These 
investigations established two lists of frequently reported 
protein abundancy changes regardless of experimental setup 
when using 2DE. Table 1 indicates which proteins overlap 
with those found in these studies, and are thus more likely 
to represent a non-specific response.
Results
Table 1 lists proteins whose abundancies changed in at 
least two proteomic studies investigating MC-LR toxicity 
in rodents or zebrafish. The data were derived from eleven 
studies that reported at least one overlapping protein whose 
abundancy changed. Five investigations applied MC-LR 
intraperitoneally, four zebrafish studies supplied the toxin 
by continuous exposure through water, one used continuous 
subcutaneous injection, and one administered MC-LR by 
oral gavage. Most studies explored the proteome using 2DE, 
although iTRAQ was applied as well. Organs interrogated 
include the liver, brain, and to a lesser extent the spleen. In 
the case of zebrafish, whole embryos were analyzed as well.
Functional Annotation
Using the Panther database (https ://panth erdb.org/, release 
13.1), functional annotation was applied to the resulting pro-
tein list to get a better overview of the molecular functions 
affected by MC-LR. To simplify this process, human 
orthologues of the found proteins were used, as well as the 
human reference database. The stacked bar plot in Fig. 1 
illustrates the gene ontology molecular functions represented 
in the liver and brain. In liver, proteins affected by MC-LR 
were mainly involved in catalytic activity (52.5%), binding 
(25.0%), and antioxidant activity (10.0%). Interestingly, in 
the brain, there was an increase in structural molecule activ-
ity when compared to liver (19.0% in brain, 5.0% in liver), 
whereas other overlapping categories remained largely the 
same.
Overrepresentation Tests
Statistical overrepresentation tests were carried out for the 
molecular functions represented in liver (Table 2) and brain 
(Table 3). In these tests, the input list (i.e., altered liver or 
brain proteins from Table 1) is categorized on the basis of 
specific classes (e.g., molecular function). The resulting 
list is then compared to a reference genome, which has also 
been grouped based on specific classes, in order to determine 
which classes are under-or overrepresented in the input list 
(Mi et al. 2013). For liver, proteins involved in molecular 
functions peroxidase, antioxidant, and oxidoreductase activ-
ity were significantly overrepresented (Table 2). Catalytic 
activity was overrepresented as well. Molecular functions 
significantly overrepresented in the brain were antioxidant 
activity, structural constituent of the cytoskeleton, structural 
molecule activity, oxidoreductase activity, and catalytic 
activity (Table 3).
Discussion
This review has identified 39 proteins whose abundancies 
were changed in at least two proteomic studies investigat-
ing MC-LR toxicity (Table 1). Many of these studies chose 
experimental designs that allow high bioavailability of the 
toxin. Indeed, the most common administration route was 
by IP and the lowest toxin concentration reported for this 
method was 1 µg/kg bodyweight, which is 25 times higher 
than the 0.04 µg/kg bodyweight TDI set by the WHO. 
While to our knowledge MC-LR bioavailability has not 
been compared between animals dosed intraperitoneally 
and orally, it seems reasonable to assume that dosing 
intraperitoneally would lead to a much higher absorption 
rate of the toxin. The lowest dose orally administered was 
40 µg/kg bodyweight (excluding continuous exposure in 
water for zebrafish), which is a thousand times higher than 
the TDI. All this puts into question whether the observed 
effects are truly specific to MC-LR exposure, or whether 
they represent a more general toxin response caused by 
toxin overload.
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In fact, several studies found that certain proteins fre-
quently exhibit abundancy changes in 2DE studies inde-
pendent of the experimental conditions (Petrak et al. 2008; 
Wang et al. 2009; Mariman 2009). Petrak and colleagues 
established a list of top-15 generally detected proteins 
(Petrak et al. 2008), whereas a different study listed 44 
proteins whose abundancies changed frequently across 
2DE experiments (Wang et al. 2009). Table 1 indicates 
which potential MC-LR biomarkers overlap with the top 
15 and top 44 of frequently reported proteins in 2DE anal-
yses. Indeed, 12 proteins listed in Table 1 overlap with 
the frequently reported protein biomarkers, i.e., 30.8% of 
all proteins found in this review. Because these studies 
did not look at commonly reported proteins derived from 
2DE analyses on zebrafish samples, this percentage may 
even be an underestimate, as it seems likely that certain 
zebrafish proteins could have the tendency to be detected 
more frequently than others, regardless of experimental 
setup.
The overrepresentation of certain proteins when using 
the 2DE method could have various reasons. It could be 
inherent to the 2DE technique allowing good visualization 
of proteins with certain properties, although this would not 
explain why their abundancies differ so frequently (Mari-
man 2009). In addition, cells are equipped with various 
stress response mechanisms that are phylogenetically con-
served (Kultz 2003), and subtle changes in a cell’s envi-
ronment could trigger these (orthologous) pathways across 
multiple species. This could explain why certain proteins 
are repeatedly affected in many studies: they may repre-
sent a general and conserved stress response. Importantly, Ta
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Fig. 1  Proportional representation of gene ontology molecular func-
tions affected by MC-LR toxicity in liver and brain based on proteins 
whose abundancy levels changed in at least two proteomic stud-
ies (Table 1). In the liver, proteins affected by MC-LR were mainly 
involved in catalytic activity (52.5%), binding (25.0%), and antioxi-
dant activity (10.0%). As for the brain, there was an increase in struc-
tural molecule activity when compared to liver (19.0% in brain, 5.0% 
in liver), whereas other overlapping categories remained largely the 
same
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one shortcoming of the current proteomics literature on 
MC-LR toxicity is that nearly all work in mammals has 
been carried out using the 2DE technique. It would be 
interesting to see more studies exploring the effect of 
MC-LR on the proteome using different techniques, for 
example by employing shotgun proteomics or iTRAQ, to 
eliminate any possible bias generated by the 2DE method.
The large overlap of a vast number of proteins across 
multiple studies regardless of experimental conditions is 
problematic for data interpretation. This study attempted 
to tackle this issue by creating a list of proteins whose 
abundancies changed in at least two studies, and to flag 
those that are commonly represented in proteomic studies 
(Table 1), based on the top-15 and top-44 lists of frequently 
reported proteins in 2DE analyses (Petrak et al. 2008; Wang 
et al. 2009). This strategy increases the likelihood that the 
non-flagged proteins in Table 1 represent a specific stress 
response to MC-LR, but since the evidence is only cir-
cumstantial, more specific research on individual proteins 
would be required to confidently link an effect to MC-LR 
toxicity. The flagged proteins were nevertheless included in 
this review because while they may be reported commonly 
across many 2DE analyses and could therefore represent a 
more general stress response, they may still provide insights 
into MC-LR toxicity.
It should also be noted that it is difficult to compare a 
toxin’s effect across multiple organisms (and tissues), as 
MC-LR may affect the zebrafish proteome differently than 
the rodent proteome. Nevertheless, it is reasonable to assume 
that similar cellular pathways are affected by MC-LR tox-
icity across different species and tissues. In addition, the 
limited number of proteomic studies on MC-LR toxicity 
performed per model organism make it difficult to effec-
tively compare the published results for one species only. 
Due to these reasons, the choice was made to compare the 
proteomes of mice, rats, and zebrafish together, as these 
organisms have been employed most frequently in MC-LR 
proteomic studies.
To summarize, the goal of Table 1 is twofold. Firstly, 
it aims to connect proteomic studies investigating MC-LR 
toxicity in rodents and zebrafish to find common patterns 
in protein abundancy changes, and secondly to stimulate 
hypothesis generation.
Overrepresented Molecular Functions
The data derived from the overrepresentation tests show 
that proteins whose abundancies consistently changed after 
MC-LR exposure are often involved in antioxidant and oxi-
doreductase activity (Tables 2 and 3). This is in agreement 
with the widely supported theory that MC-LR induces oxida-
tive stress by promoting reactive oxygen species (ROS) for-
mation (Zegura 2016). For example, low concentrations of 
MC-LR induced double strand DNA breaks in HepG2 cells 
(Zegura et al. 2003). The same study found that digestion of 
Table 2  Molecular functions 
overrepresented in proteomic 
studies that investigated MC-LR 
toxicity in the liver
a p values calculated by the PANTHER algorithm using the Fisher’s exact test with FDR multiple test cor-
rections. The gene ontology molecular function classes of the reported liver proteins were compared with 
the gene ontology molecular function classes of the Homo sapiens database (PANTHER release 13.1)
Molecular function Observed Expected p  valuea False discovery rate
Peroxidase activity 3 0.04 1.02E−05 4.87E−04
Antioxidant activity 4 0.05 3.47E−07 3.33E−05
Oxidoreductase activity 7 0.76 9.29E−06 5.94E−04
Catalytic activity 21 6.41 2.84E−08 5.46E−06
Table 3  Molecular functions 
overrepresented in proteomic 
studies that investigated MC-LR 
toxicity in the brain
a p values calculated by the PANTHER algorithm using the Fisher’s exact test with FDR multiple test cor-
rections. The gene ontology molecular function classes of the reported brain proteins were compared with 
the gene ontology molecular function classes of the Homo sapiens database (PANTHER release 13.1)
Molecular function Observed Expected P  valuea False discovery rate
Antioxidant activity 2 0.03 4.51E−04 4.33E−02
Structural constituent of cytoskeleton 3 0.22 1.25E−03 4.00E−02
Structural molecule activity 4 0.43 7.88E−04 5.04E−02
Oxidoreductase activity 5 0.43 5.29E−05 1.02E−02
Catalytic activity 10 3.61 9.33E−04 4.48E−02
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DNA with endonucleases specific for oxidative DNA dam-
age increased DNA strand breaks in MC-LR-treated cells, 
indicating that oxidative stress is responsible. Genotoxicity 
by MC-LR has also been reported in human peripheral blood 
lymphocytes (Mankiewicz et al. 2002; Zegura et al. 2011), 
human colon adenocarcinoma cell line CaCo-2 (Zegura et al. 
2008), and hamster ovary cells (Wang et al. 2013). Indeed, 
the data from Table 1 are consistent with the theory that 
MC-LR induces oxidative stress and may help to identify 
key players involved in this process that may not had been 
considered previously.
The results from the functional annotation analysis 
(Fig. 1) and overrepresentation tests (Tables 2 and 3) also 
indicate that proteins involved in cytoskeletal processes are 
affected by MC-LR, especially in the brain. There could be 
several reasons as of why the cytoskeleton appears more 
affected by MC-LR in the brain than in the liver. Since 
hepatocytes and neurons are different cell types, they could 
be affected differently by the toxin. Furthermore, MC-LR 
is transported into hepatocytes and across the blood brain 
barrier by organic-anion-transporting polypeptides (OATPs), 
which are membrane solute carriers that transport a wide 
range of amphipathic transport substrates (Hagenbuch and 
Meier 2003). In humans, members OATP1B1 and OATP1B3 
transfer MC-LR across the cell membrane into hepatocytes 
(Komatsu et al. 2007), whereas OATP1A2 is responsible 
for MC-LR uptake through the blood–brain barrier (Fischer 
et al. 2005). Perhaps, MC-LR’s use of different transport-
ers leads to different exposure conditions in various organs. 
Additionally, MC-LR is thought to bioaccumulate at a higher 
rate in the liver than in the brain (Falconer et al. 1986; Wang 
et al. 2008), and perhaps these differences in toxin concen-
tration lead to different cellular responses.
In general, the effects of MC-LR on the cytoskeleton 
could be a result of PP2A inhibition. Indeed, more than 
30 protein kinase activities are regulated by PP2A in vitro 
(Millward et al. 1999). Some of these kinases are involved 
in cytoskeletal regulation, such as MAP kinase-activated 
protein kinase 2 (Millward et al. 1999; Zhou et al. 2015). It 
is plausible that MC-LR indirectly perturbs the cytoskeleton 
via PP2A inhibition. Because cytoskeleton and cytoskeleton-
associated proteins are often involved in signal transduc-
tion (Wickstead and Gull 2011), MC-LR exposure could 
lead to disruptions within cell signaling pathways (Zhou 
et al. 2015), causing a wide range of complications. This 
may explain why proteins involved in an array of different 
functions have consistently been reported altered in multiple 
proteomic studies (Table 1).
To summarize, functional annotations (Fig. 1) and over-
representation tests (Tables 2 and 3) suggest that MC-LR 
predominantly induces antioxidant activity in both the liver 
and brain, whereas in the brain the cytoskeleton appears 
more strongly affected than in the liver.
Abundancy Changes of Individual Proteins
While functional classification of proteins provides valuable 
information on the general mechanisms affected, it is also 
important to look individually at each protein influenced by 
MC-LR toxicity to determine in which studies a protein’s 
level is consistently up-or downregulated. As mentioned pre-
viously, a subset of key cytoskeletal proteins shows recurring 
changes in abundancy across a number of proteomic studies. 
The observed trend is a general decrease in protein levels 
after MC-LR exposure (Table 1). These include chains of 
the microtubule protein tubulin, namely tubulin alpha-1C 
chain (Li et al. 2012a; Zhao et al. 2015) and tubulin beta-
4B chain (Li et al. 2012a, b). Microtubules are polymers of 
tubulin dimers that form the spindle structure, which ena-
bles chromosome segregation during mitosis and meiosis 
(Gadde and Heald 2004). It was shown in CHO-K1 cells that 
MC-LR exposure leads to the formation of aberrant spindles 
(Lankoff et al. 2003). Cells treated with MC-LR showed 
abnormal anaphases with defective chromosome separation. 
This effect correlated with the formation of aberrant mitotic 
spindles, indicating that MC-LR exposure leads to the for-
mation of dysfunctional spindles and thereby hinders cell 
division (Lankoff et al. 2003).
As can be seen in Table 1, levels of microfilament actin 
(cytoplasmic 1) also underwent a general decline after 
MC-LR exposure (Wang et al. 2010b; Li et al. 2011a, 2012b; 
Zhao et al. 2012). Multiple studies have shown that MC-LR 
causes microfilament disorganization (Zhou et al. 2015). 
For example, Batista and colleagues found that actin fila-
ments collapsed in primary human hepatocytes treated with 
MC-LR (Batista et al. 2003). In a different study, primary 
rat hepatocytes underwent microfilament disorganization 
after MC-LR treatment (Ding et al. 2001). The authors also 
found an increase in ROS formation, and they suggested 
that the cytoskeleton disorganization may be a result of the 
increased presence of ROS. In conclusion, there is a substan-
tial amount of evidence supporting the theory that MC-LR 
causes cytoskeletal disruption, which has been reviewed 
in more detail recently (Zhou et al. 2015). The data gener-
ated by multiple proteomic studies support the theory that 
MC-LR perturbs cytoskeletal processes.
As mentioned previously, MC-LR causes cellular dis-
ruption by inducing ROS formation. MC-LR therefore indi-
rectly induces oxidative stress, a process known to cause 
genotoxicity. This subject has been reviewed in great detail 
recently (Zegura 2016). As can be seen in Table 1, numer-
ous proteins involved in oxidoreductase activity and defense 
against oxidative stress were affected by MC-LR toxicity. 
These include members of the peroxiredoxin family, which 
are antioxidant enzymes that guard cells against oxida-
tive stress and regulate intracellular dihydrogen peroxide 
 (H2O2) levels (Rhee et al. 2001). Peroxiredoxin-2 showed 
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increased levels in both the rat hippocampus (Li et al. 2012a) 
and mouse liver (Chen et al. 2005) after MC-LR treatment 
(Table 1). While peroxiredoxin-2 regulates endogenous 
 H2O2 signaling (Choi et al. 2005), it also protects metastatic 
cells in the lungs from oxidative stress (Stresing et al. 2013). 
Indeed, Stresing and colleagues found that lung metastatic 
variants of MDA-MB-435 breast cancer cells were less sus-
ceptible to oxidative stress, which correlated with increased 
levels of peroxiredoxin-2. Contrary to the peroxiredoxin-2 
effects, two proteomic studies reported decreased quantities 
of peroxiredoxin-6 after MC-LR treatment (Chen et al. 2005; 
Zhao et al. 2012), whereas levels of peroxiredoxin-1 were 
inconsistent across two studies (Chen et al. 2005; Li et al. 
2012b). These variations could be due to the different regen-
eration mechanisms inherent to the peroxiredoxin family 
members (Chevallet et al. 2003). After oxidative stress, per-
oxiredoxin-2 is the first to regenerate, while peroxiredoxin-1 
and peroxiredoxin-6 regenerate more slowly (Chevallet et al. 
2003). This indicates that while cells recover from oxidative 
stress, peroxiredoxin-2 levels increase at a much faster rate 
than the other peroxiredoxins, which could explain the vari-
ations found in peroxiredoxin levels after MC-LR treatment 
(Chen et al. 2005).
Another protein involved in ROS clean-up is Cu/Zn 
superoxide dismutase, which showed increased quanti-
ties in two proteomic studies (Wang et al. 2010a; Li et al. 
2012a). Superoxide dismutases form the first line of defense 
against ROS, superoxides in particular (Zelko et al. 2002). 
They contain a metal ion cofactor that allows them to add or 
remove an electron from the superoxide and convert it into 
less toxic oxygen and  H2O2 (Culotta et al. 2006).
Importantly, it should be noted that peroxiredoxin and 
Cu/Zn superoxide dismutase levels are often changed in 
proteome studies regardless of experimental setup (Petrak 
et al. 2008; Wang et al. 2009). This means that these effects 
could simply represent a general toxin response and may not 
be specific for MC-LR toxicity.
Levels of ferritin light chain, a subunit of the ferritin 
protein, also increased after MC-LR exposure in two prot-
eomic studies (Chen et al. 2005; Zhao et al. 2012). Ferritin 
is involved in iron (Fe) storage by binding Fe(II) in its fer-
roxidase center, where either  H2O2 or oxygen are used to 
oxidize Fe(II) to Fe(III) (Arosio and Levi 2002; Arosio et al. 
2009). The iron then migrates to the ferritin cavity where it 
nucleates and forms the iron core. This process allows the 
concentration and safe storage of up to 4000 iron atoms, 
which are readily available when required. Importantly, it 
prevents the spontaneous oxidation of Fe(II) to Fe(III), a 
reaction that generates ROS (Arosio et al. 2009). Indeed, 
ferritin prevents free radical production by isolating Fe(II) 
atoms and thereby guards the cell against oxidative stress. 
Since MC-LR induces the formation of ROS, perhaps the 
cell responds by generating more ferritin to clear other 
sources of ROS formation from the cell.
Levels of heterogeneous nuclear ribonucleoprotein K 
(HNRNPK) were increased in two proteomic studies (Li 
et al. 2012b; Zhao et al. 2016). HNRNPK is a transcrip-
tional cofactor of p53, a widely studied transcription factor 
known for its tumor-suppressing capabilities (Moumen et al. 
2005). Also known as the “guardian of the genome", p53 is 
involved in many cellular activities, including DNA repair 
and defense against oxidative stress (Nicolai et al. 2015). 
Perhaps cells produce more HNRNPK to activate defense 
mechanisms through p53 in order to fight oxidative stress 
caused by MC-LR toxicity.
Two studies reported an increased abundance of sele-
nium-binding protein 1 (Li et al. 2012b; Chen et al. 2017), 
which covalently binds selenium and participates in intra-
Golgi protein transport (Porat et al. 2000; Jeong et al. 2009). 
It also takes part in toxification and detoxification processes 
(Papp et al. 2007). Interestingly, selenium supplementa-
tion prior to MC-LR administration provided some protec-
tion against hepatotoxicity in mice (Gehringer et al. 2003). 
Indeed, selenium pretreatment resulted in less severe liver 
injury, as well as decreased serum ALT and lipid peroxida-
tion levels compared to rodents that received MC-LR alone. 
The proteomics data suggest that selenium pathways play a 
role in MC-LR toxicity. It may be interesting to research this 
finding in more detail, especially as selenium supplemen-
tation has been reported to guard against MC-LR toxicity 
(Gehringer et al. 2003).
Human Health Implications
Overall, the proteomic studies investigating MC-LR tox-
icity in rodents and zebrafish have illustrated that a wide 
array of molecular functions are affected. However, these 
experiments have been performed in animals under varying 
experimental conditions that do not allow easy comparison, 
and thus the key question remains what these results mean 
in terms of human exposure to MC-LR.
Importantly, it should be pointed out that the toxin con-
centrations used in all discussed proteomic studies were 
extremely high (Table 1). The lowest oral dose applied in 
mammals was 40 µg/kg bodyweight (He et al. 2017), or a 
thousand times the TDI. To put this into perspective, fish-
ermen who had been living for at least five years on a lake 
regularly plagued by cyanobacterial blooms were estimated 
to consume a daily amount of 2.2 to 3.9 µg of MC-LR equiv-
alents per person (Chen et al. 2009). For a person weigh-
ing 60 kg, this roughly translates to 0.037 to 0.065 µg/kg 
bodyweight, and thus the estimated intake of these fishermen 
was close to the TDI of 0.04 µg/kg bodyweight set by the 
WHO. The fishermen would thus need to increase their daily 
MC-LR intake roughly a thousand times in order to meet 
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the lowest applied dose in mammals in a proteomic study 
(40 µg/kg bodyweight), and this puts into question how the 
results translate to human exposure conditions. The time-
frames applied in these proteomic studies were often rela-
tively short (Table 1), not exceeding three months, whereas 
the fishermen had been living on the lake for at least five 
years. This reveals two complications in the current MC-LR 
proteomics literature that make it difficult to translate these 
results into a human scenario. Firstly, the MC-LR concentra-
tions dosed are extremely high, and secondly, the experiment 
durations are relatively short.
Interestingly, a non-proteomic study did look at the effect 
of low dose MC-LR toxicity on mice over several periods 
of months, the longest being 18 months (Ueno et al. 1999). 
The animals received 20 µg MC-LR/L in their drinking 
water, which translates to twenty times the guideline value 
of 1 µg/L set by the WHO for MC-LR in drinking water 
(Chorus and Bartram 1999). The authors looked at hematol-
ogy and serum biochemistry parameters, as well as histopa-
thology of various organs. No signs of chronic toxicity were 
found and no MC-LR was detected in the livers. Importantly, 
these results derive from an experiment that more closely 
mimicked exposure conditions relevant to humans, and they 
provide no proof that MC-LR is toxic under these experi-
mental conditions. Unfortunately, the authors did not look 
at the proteome, which perhaps would have allowed detec-
tion of more subtle changes in protein levels in response to 
MC-LR exposure.
As mentioned previously, the findings reported in this 
review reinforce the theory that MC-LR induces oxidative 
stress, a process implicated with carcinogenesis (Klaunig 
and Kamendulis 2004). It should also be noted that while 
oxidative stress markers were regularly found affected in the 
proteome studies, these effects could also reflect a general 
stress response and may not have a role in carcinogenesis. 
Nevertheless, the finding correlates with the fact that sev-
eral epidemiology studies have linked MC-LR exposure to 
increased incidences of cancer. For example, a positive cor-
relation was found between the incidence rate of colorectal 
cancer and people who used water from ponds and rivers 
that contained microcystins, compared to those who used 
well and tap water (Lun et al. 2002). In addition, Ueno and 
colleagues found a correlation between microcystin levels 
in drinking water and the incidence of primary liver can-
cer in Haimen city, China (Ueno et al. 1996). In the same 
article, however, the authors write that major foodstuffs in 
Haimen City contained aflatoxin B1, a carcinogen known 
to affect the liver (Bennett and Klich 2003). This illustrates 
the difficulty of interpreting results from epidemiology stud-
ies, as they only indicate correlations, but no direct proof. 
In all epidemiology studies investigating MC-LR toxicity, 
the participants could have been exposed to a wide array of 
toxins present in their water sources, making it extremely 
challenging to pinpoint MC-LR as the (sole) contributor of 
the measured effects. This further stresses the need for ani-
mal studies that better mimic human exposure conditions, 
preferably ones that take a systems biology approach to 
study different levels of biological organization.
To summarize, it would be interesting to study the effect 
of chronic low-dose MC-LR exposure on the proteome over 
a longer period of time, thus better portraying a realistic 
human scenario. The findings in Table 1 help highlight pro-
teins whose abundancies changed in response to MC-LR 
toxicity in at least two studies, however, the question remains 
whether they would also be affected in humans that are 
chronically exposed to low MC-LR amounts. Indeed, more 
proteomic studies accurately portraying human exposure 
conditions are needed to better understand how the human 
proteome could be affected.
Conclusion
A large number of studies have looked at the effect of 
MC-LR toxicity on the proteome, generating a substan-
tial list of potential biomarkers. It is difficult to determine 
which of the observed effects are MC-LR specific. Indeed, 
some proteins may show altered levels due to a general toxin 
response, whereas others may be influenced by other factors 
(e.g., experimental design). However, a protein’s response 
is more likely to be caused by the toxin if the results are 
repeated in more than one proteomic study. This review 
identified 39 proteins that were affected in at least two pro-
teomic studies investigating MC-LR toxicity and flagged 
those that are commonly found in 2DE analyses regardless 
of experimental setup (Table 1).
One consistent effect reported by proteomic studies is the 
decreased levels of cytoskeletal components after MC-LR 
exposure. These include tubulin microtubules and actin 
microfilaments (Table 1). The adverse effects of MC-LR 
on the cytoskeleton have been reviewed in detail previously 
(Zhou et al. 2015), and this review helps identify the pos-
sible key players involved. Evidence suggests that MC-LR 
induces oxidative stress, which leads to genotoxicity and 
possibly carcinogenicity (Zegura 2016). Further studies 
on the proteins listed in Table 1 may shed more light on 
the genotoxic and possible carcinogenic effects of MC-LR. 
Other proteins whose levels were perturbed by MC-LR 
include those that play a role in calcium binding, protein 
folding, and metabolism, which could be due to PP2A regu-
lating a wide range of cell signaling pathways (Millward 
et al. 1999). Indeed, the proteins from Table 1 illustrate that 
MC-LR exposure affects many components of the cellular 
machinery.
However, it should be pointed out that the available data 
are limited, and it is difficult to adequately compare results 
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from multiple species and tissue types. Because of the 
extreme experimental conditions applied (high toxin doses 
and relatively short timeframes), it is challenging to translate 
these results into a human exposure scenario. More data 
from MC-LR proteomic studies, preferably performed in 
mammals using low oral MC-LR concentrations, would help 
shed more light onto the effect of MC-LR on the proteome. 
A low oral dose is key as it would better represent human 
exposure conditions. Furthermore, because MS-based meth-
ods such as shotgun proteomics and iTRAQ are underrepre-
sented in the current literature, it would be a valuable addi-
tion to explore the effect of MC-LR on the proteome using 
these techniques.
To conclude, this review exposes consistently reported 
proteins affected by MC-LR exposure that may not had been 
considered previously, opening new doors to understanding 
the mechanisms behind MC-LR toxicity. Additional research 
will be required to verify these results.
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